Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2011

Jan 28, 2011

33819_dirs_2011-01-27_1f759bea-7b26-41ae-832e-21c332d8ce09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2011-01-26

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-26 Common Stock A 3519 $0.25 Acquired 356400 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 190111 Indirect

Footnotes

F1: The $0.25 per share price was the stock option exercise price for shares granted to Dr. Weissman on February 6, 2001, March 29, 2001 and March 31, 2001.

F2: Includes (1) exercise of shares granted to Dr. Weissman on October 6, 2000, November 3, 2000, December 31, 2000 and January 2, 2001, and (2) anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2011, the one year anniversary of the grant.

F3: 105,079 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.